Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 41, 773-779, March 1, 1981]
© 1981 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hennings, H.
Right arrow Articles by Yuspa, S. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hennings, H.
Right arrow Articles by Yuspa, S. H.

Comparison of Two-Stage Epidermal Carcinogenesis Initiated by 7,12-Dimethylbenz(a)anthracene or N-Methyl-N'-nitro-N-nitrosoguanidine in Newborn and Adult SENCAR and BALCB/c Mice

Henry Hennings1, Deborah Devor, Martin L. Wenk, Thomas J. Slaga, Brigitte Former, Nancy H. Colburn, G. T. Bowden, Kjell Elgjo and Stuart H. Yuspa

In Vitro Pathogenesis Section, Laboratory of Experimental Pathology, National Cancer Institute, Bethesda, Maryland 20205 [H. H., B. F., N. H. C., G. T. B., S. H. Y.]; Microbiological Associates, Bethesda, Maryland 20016 [D. D., M. L. W.]; Biology Division, Oak Ridge National Laboratories, Oak Ridge, Tennessee 37836 [T. J. S.]; and Institute for Pathology, Rikshospitalet, Oslo, Norway [K. E.]

In order to define factors which determine susceptibility to chemical carcinogenesis, mice sensitive (SENCAR) and resistant (BALB/c) to epidermal carcinogenesis were studied under several treatment conditions for sensitivity to initiation by 7,12-dimethylbenz(a)anthracene or N-methyl-N'-nitro-N-nitrosoguanidine and promotion by 12-O-tetradecanoylphorbol-13-acetate. In newborns of both strains, topical application of initiator was much less effective than in adults. However, initiation by i.p. injection of 7,12-dimethylbenz(a)anthracene is at least as effective in newborns as in adults, which may indicate that topically applied carcinogen is not delivered effectively to target cells in newborns. Thus, newborn epidermis can respond to 7,12-dimethylbenz(a)anthracene as well as adult epidermis when the initiator is appropriately administered. SENCAR mice are much more sensitive than are BALB/c mice to both initiators, which suggests that enhanced metabolic activation of hydrocarbon carcinogens by SENCAR mice is unlikely to account for their sensitivity. Newborn male SENCAR's developed approximately 50% more papillomas than did females in all groups. BALB/c newborn mice developed so few tumors that a meaningful comparison of sensitivity of males and females could not be made. Thus, the increased sensitivity of SENCAR's was apparent regardless of route of administration of initiator or the age or sex of the mice. SENCAR mice also developed a significant number of papillomas and squamous cell carcinomas with 12-O-tetradecanoylphorbol-13-acetate promotion in the absence of an exogenous initiator. Therefore, the skin of SENCAR mice may contain an initiated population of cells capable of responding to tumor promoters.

1 To whom requests for reprints should be addressed, at NIH, Building 37, Room 3A21, Bethesda, Md. 20205.

Received 7/14/80. Accepted 11/11/80.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
K. Ridd, S.-D. Zhang, R. E. Edwards, R. Davies, P. Greaves, A. Wolfreys, A. G. Smith, and T. W. Gant
Association of gene expression with sequential proliferation, differentiation and tumor formation in murine skin
Carcinogenesis, August 1, 2006; 27(8): 1556 - 1566.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
C. D. Woodworth, E. Michael, L. Smith, K. Vijayachandra, A. Glick, H. Hennings, and S. H. Yuspa
Strain-dependent differences in malignant conversion of mouse skin tumors is an inherent property of the epidermal keratinocyte
Carcinogenesis, September 1, 2004; 25(9): 1771 - 1778.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. A. Hansen, D. Brown, V. Virador, T. Tanaka, F. Andreola, K. Strain, B. Dancheck, R. Riley, J. M. Arbeit, L. M. De Luca, et al.
A PMLRARA Transgene Results in a Retinoid-deficient Phenotype Associated with Enhanced Susceptibility to Skin Tumorigenesis
Cancer Res., September 1, 2003; 63(17): 5257 - 5265.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
B. S. Han, K. Fukamachi, N. Takasuka, T. Ohnishi, M. Maeda, T. Yamasaki, and H. Tsuda
Inhibitory effects of 17{beta}-estradiol and 4-n-octylphenol on 7,12-dimethylbenz[a]anthracene-induced mammary tumor development in human c-Ha-ras proto-oncogene transgenic rats
Carcinogenesis, July 1, 2002; 23(7): 1209 - 1215.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Miyata, G. Kudo, Y.-H. Lee, T. J. Yang, H. V. Gelboin, P. Fernandez-Salguero, S. Kimura, and F. J. Gonzalez
Targeted Disruption of the Microsomal Epoxide Hydrolase Gene. MICROSOMAL EPOXIDE HYDROLASE IS REQUIRED FOR THE CARCINOGENIC ACTIVITY OF 7,12-DIMETHYLBENZ[a]ANTHRACENE
J. Biol. Chem., August 20, 1999; 274(34): 23963 - 23968.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
S.W. Dean, T.M. Brooks, B. Burlinson, J. Mirsalis, B. Myhr, L. Recio, and V. Thybaud
Transgenic mouse mutation assay systems can play an important role in regulatory mutagenicity testing in vivo for the detection of site-of-contact mutagens
Mutagenesis, January 1, 1999; 14(1): 141 - 151.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1981 by the American Association for Cancer Research.